B

Biofrontera Inc. (BFRI)

NCM – Real vaqt narxi. Valyuta: USD

1.25

+0.03 (2.46%)

Yopilishda: Aug 12, 2026, 4:00 PM EDT

1.24

-0.01 (-0.76%)

Bozordan keyin: Aug 12, 2026, 6:11 PM EDT

Aksiya tahlili uchun eng kuchli vositalarga ega bo'ling

Finranks

Kompaniya

Biz haqimizda

Biz bilan bog'lanish

[email protected]

Bizni kuzating

Barcha huquqlar himoyalangan.

Foydalanish shartlari

B

Biofrontera Inc. (BFRI)

NCM – Real vaqt narxi. Valyuta: USD

1.25

+0.03 (2.46%)

Yopilishda: Aug 12, 2026, 4:00 PM EDT

1.24

-0.01 (-0.76%)

Bozordan keyin: Aug 12, 2026, 6:11 PM EDT

05.08.2026

Biofrontera Inc. to Report Second Quarter 2026 Financial Results on August 13, 2026

WOBURN, Mass., Aug. 05, 2026 (GLOBE NEWSWIRE) -- Biofrontera Inc. (NASDAQ: BFRI) ("Biofrontera" or the "Company"), a U.S. specialty dermatology company commercializing Ameluz® (aminolevulinic acid hydrochloride) Gel, 10% with the BF-RhodoLED® lamp for photodynamic therapy (PDT) of actinic keratosis, today announced that it will report financial results for the second quarter ended June 30, 2026 before the market opens on Thursday, August 13, 2026.

Videolar

No Data

There is no data to display

Search stocks

Biofrontera Inc. (BFRI)

Aksiya tahlili uchun eng kuchli vositalarga ega bo'ling

Finranks

Kompaniya

Biz bilan bog'lanish

Bizni kuzating

Biofrontera Inc. (BFRI)

Biofrontera Inc. to Report Second Quarter 2026 Financial Results on August 13, 2026

Videolar

No Data